Literature DB >> 23859271

De novo sequencing with limited number of post-translational modifications per peptide.

Lin He1, Xi Han, Bin Ma.   

Abstract

De novo sequencing derives the peptide sequence from a tandem mass spectrum without the assistance of protein databases. This analysis has been indispensable for the identification of novel or modified peptides in a biological sample. Currently, the speed of de novo sequencing algorithms is not heavily affected by the number of post-translational modification (PTM) types in consideration. However, the accuracy of the algorithms can be degraded due to the increased search space. Most peptides in a proteomics research contain only a small number of PTMs per peptide, yet the types of PTMs can come from a large number of choices. Therefore, it is desirable to include a large number of PTM types in a de novo sequencing algorithm, yet to limit the number of PTM occurrences in each peptide to increase the accuracy. In this paper, we present an efficient de novo sequencing algorithm, DeNovoPTM, for such a purpose. The implemented software is downloadable from http://www.cs.uwaterloo.ca/~l22he/denovo_ptm .

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23859271     DOI: 10.1142/S0219720013500078

Source DB:  PubMed          Journal:  J Bioinform Comput Biol        ISSN: 0219-7200            Impact factor:   1.122


  3 in total

1.  A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.

Authors:  Qiang Kou; Si Wu; Nikola Tolic; Ljiljana Paša-Tolic; Yunlong Liu; Xiaowen Liu
Journal:  Bioinformatics       Date:  2017-05-01       Impact factor: 6.937

2.  Novor: real-time peptide de novo sequencing software.

Authors:  Bin Ma
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-30       Impact factor: 3.109

Review 3.  Toward a systems-level view of dynamic phosphorylation networks.

Authors:  Robert H Newman; Jin Zhang; Heng Zhu
Journal:  Front Genet       Date:  2014-08-15       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.